Molecules found in blood or urine whose concentrations vary within or among individuals, reflecting disease risks of the subjects, are called disease biomarkers. Measurement of such biomarkers can provide valuable information for disease prevention and early diagnosis. The Group of Omics Analysis aims to discover useful biomarkers through the global identification and quantification (i.e. multi-omics studies) of proteins and small compounds found in blood or urine specimens provided by cohort-study participants. Such multi-omics studies can contribute to advancement of personalized prevention and treatment of diseases, as well as identification of disease mechanisms and development of novel therapeutics.
See details >